-
Je něco špatně v tomto záznamu ?
Germline multigene panel testing of patients with endometrial cancer
J. Kral, S. Jelinkova, P. Zemankova, M. Vocka, M. Borecka, L. Cerna, M. Cerna, L. Dostalek, P. Duskova, L. Foretova, O. Havranek, K. Horackova, M. Hovhannisyan, S. Chvojka, M. Kalousova, M. Kosarova, M. Koudova, V. Krutilkova, E. Machackova, P....
Status neindexováno Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2010
ProQuest Central
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
37153042
DOI
10.3892/ol.2023.13802
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. The present study aimed to determine the frequency of germline pathogenic variants (PV) in patients with EC. In this multicenter retrospective cohort study, germline genetic testing (GGT) was performed in 527 patients with EC using a next generation sequencing panel targeting 226 genes, including 5 Lynch syndrome (LS) and 14 hereditary breast and ovarian cancer (HBOC) predisposition genes, and 207 candidate predisposition genes. Gene-level risks were calculated using 1,662 population-matched controls (PMCs). Patients were sub-categorized to fulfill GGT criteria for LS, HBOC, both or none. A total of 60 patients (11.4%) carried PV in LS (5.1%) and HBOC (6.6%) predisposition genes, including two carriers of double PV. PV in LS genes conferred a significantly higher EC risk [odds ratio (OR), 22.4; 95% CI, 7.8-64.3; P=1.8×10-17] than the most frequently altered HBOC genes BRCA1 (OR, 3.9; 95% CI, 1.6-9.5; P=0.001), BRCA2 (OR, 7.4; 95% CI, 1.9-28.9; P=0.002) and CHEK2 (OR, 3.2; 95% CI, 1.0-9.9; P=0.04). Furthermore, >6% of patients with EC not fulfilling LS or HBOC GGT indication criteria carried a PV in a clinically relevant gene. Carriers of PV in LS genes had a significantly lower age of EC onset than non-carriers (P=0.01). Another 11.0% of patients carried PV in a candidate gene (the most frequent were FANCA and MUTYH); however, their individual frequencies did not differ from PMCs (except for aggregated frequency of loss-of-function variants in POLE/POLD1; OR, 10.44; 95% CI, 1.1-100.5; P=0.012). The present study demonstrated the importance of GGT in patients with EC. The increased risk of EC of PV carriers in HBOC genes suggests that the diagnosis of EC should be included in the HBOC GGT criteria.
BIOCEV 1st Faculty of Medicine Charles University Prague 252 50 Czech Republic
Center for Medical Genetics and Reproductive Medicine Gennet Prague 170 00 Czech Republic
Department of Biochemistry Faculty of Science Charles University Prague 120 00 Czech Republic
Department of Medical Genetics Pronatal Prague 140 00 Czech Republic
Laboratory of Molecular Genetics Hospital Ceske Budejovice Ceske Budejovice 370 00 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009657
- 003
- CZ-PrNML
- 005
- 20240321100836.0
- 007
- ta
- 008
- 230707s2023 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ol.2023.13802 $2 doi
- 035 __
- $a (PubMed)37153042
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Král, Jan, $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $d 1985- $7 xx0225291
- 245 10
- $a Germline multigene panel testing of patients with endometrial cancer / $c J. Kral, S. Jelinkova, P. Zemankova, M. Vocka, M. Borecka, L. Cerna, M. Cerna, L. Dostalek, P. Duskova, L. Foretova, O. Havranek, K. Horackova, M. Hovhannisyan, S. Chvojka, M. Kalousova, M. Kosarova, M. Koudova, V. Krutilkova, E. Machackova, P. Nehasil, J. Novotny, B. Otahalova, A. Puchmajerova, M. Safarikova, J. Slama, V. Stranecky, I. Subrt, S. Tavandzis, M. Zikan, T. Zima, J. Soukupova, P. Kleiblova, Z. Kleibl, M. Janatova
- 520 9_
- $a Endometrial cancer (EC) is the most common gynecological malignancy in developed countries. The present study aimed to determine the frequency of germline pathogenic variants (PV) in patients with EC. In this multicenter retrospective cohort study, germline genetic testing (GGT) was performed in 527 patients with EC using a next generation sequencing panel targeting 226 genes, including 5 Lynch syndrome (LS) and 14 hereditary breast and ovarian cancer (HBOC) predisposition genes, and 207 candidate predisposition genes. Gene-level risks were calculated using 1,662 population-matched controls (PMCs). Patients were sub-categorized to fulfill GGT criteria for LS, HBOC, both or none. A total of 60 patients (11.4%) carried PV in LS (5.1%) and HBOC (6.6%) predisposition genes, including two carriers of double PV. PV in LS genes conferred a significantly higher EC risk [odds ratio (OR), 22.4; 95% CI, 7.8-64.3; P=1.8×10-17] than the most frequently altered HBOC genes BRCA1 (OR, 3.9; 95% CI, 1.6-9.5; P=0.001), BRCA2 (OR, 7.4; 95% CI, 1.9-28.9; P=0.002) and CHEK2 (OR, 3.2; 95% CI, 1.0-9.9; P=0.04). Furthermore, >6% of patients with EC not fulfilling LS or HBOC GGT indication criteria carried a PV in a clinically relevant gene. Carriers of PV in LS genes had a significantly lower age of EC onset than non-carriers (P=0.01). Another 11.0% of patients carried PV in a candidate gene (the most frequent were FANCA and MUTYH); however, their individual frequencies did not differ from PMCs (except for aggregated frequency of loss-of-function variants in POLE/POLD1; OR, 10.44; 95% CI, 1.1-100.5; P=0.012). The present study demonstrated the importance of GGT in patients with EC. The increased risk of EC of PV carriers in HBOC genes suggests that the diagnosis of EC should be included in the HBOC GGT criteria.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jelinkova, Sandra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Zemankova, Petra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague 120 00, Czech Republic
- 700 1_
- $a Vocka, Michal $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Borecka, Marianna $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Cerna, Leona $u Center for Medical Genetics and Reproductive Medicine, Gennet, Prague 170 00, Czech Republic
- 700 1_
- $a Cerna, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Dostalek, Lukas $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Duskova, Petra $u Laboratory of Molecular Genetics, Hospital Ceske Budejovice, Ceske Budejovice 370 00, Czech Republic
- 700 1_
- $a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic
- 700 1_
- $a Havranek, Ondrej $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u BIOCEV (Biotechnology and Biomedicine Center of The Czech Academy of Sciences and Charles University), First Faculty of Medicine, Charles University, Prague 252 50, Czech Republic
- 700 1_
- $a Horackova, Klara $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Hovhannisyan, Milena $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Chvojka, Štěpán, $d 1991- $u Center for Medical Genetics and Reproductive Medicine, Gennet, Prague 170 00, Czech Republic $7 xx0315271
- 700 1_
- $a Kalousova, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Kosarova, Marcela $u Department of Medical Genetics, Pronatal, Prague 140 00, Czech Republic
- 700 1_
- $a Koudova, Monika $u Center for Medical Genetics and Reproductive Medicine, Gennet, Prague 170 00, Czech Republic
- 700 1_
- $a Krutilkova, Vera $u Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin 741 00, Czech Republic
- 700 1_
- $a Machackova, Eva $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic
- 700 1_
- $a Nehasil, Petr $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague 120 00, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Novotny, Jan $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Otahalova, Barbora $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, Prague 120 00, Czech Republic
- 700 1_
- $a Puchmajerova, Alena $u Center for Medical Genetics and Reproductive Medicine, Gennet, Prague 170 00, Czech Republic
- 700 1_
- $a Safarikova, Marketa $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Slama, Jiri $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Stranecky, Viktor $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Subrt, Ivan $u Department of Medical Genetics, Faculty of Medicine in Pilsen, Charles University and University Hospital Pilsen, Pilsen 323 00, Czech Republic
- 700 1_
- $a Tavandzis, Spiros $u Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin 741 00, Czech Republic
- 700 1_
- $a Zikan, Michal $u Department of Gynecology and Obstetrics, Bulovka University Hospital and First Faculty of Medicine, Charles University, Prague 180 00, Czech Republic
- 700 1_
- $a Zima, Tomas $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Soukupova, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Kleiblova, Petra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 700 1_
- $a Kleibl, Zdenek $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague 120 00, Czech Republic
- 700 1_
- $a Janatova, Marketa $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 120 00, Czech Republic
- 773 0_
- $w MED00193499 $t Oncology letters $x 1792-1082 $g Roč. 25, č. 6 (2023), s. 216
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37153042 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20240321100830 $b ABA008
- 999 __
- $a ok $b bmc $g 1958456 $s 1195921
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 25 $c 6 $d 216 $e 20230412 $i 1792-1082 $m Oncology letters $n Oncol Lett $x MED00193499
- LZP __
- $a Pubmed-20230707
